Search for: "Deas v. Deas" Results 81 - 100 of 821
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
16 Jun 2022, 10:05 am by James Kachmar
The Ninth Circuit recently tackled this issue in AK Futures LLC v. [read post]
13 Jun 2022, 3:45 pm by Bennett Cyphers
Its current and former clients in the US government include, at a minimum, the IRS, the DHS and its subsidiaries ICE and CBP, the DEA, and the FBI. [read post]
15 May 2022, 9:11 pm by The Regulatory Review Staff
The Regulatory Review would like to thank the members of the 2021-2022 editorial board for their passion and hard work in producing this publication. [read post]
7 Dec 2021, 5:09 am by Charles Sartain
  Answer: As many as they want, but the court will only use one, says King Operating et al v. [read post]
17 Sep 2021, 12:00 pm by Caitlin Lentz
  While the PHE continues, the exception will apply and provides as follows: “DEA-registered practitioners in all areas of the United States may issue prescriptions for all schedule II-V controlled substances to patients for whom they have not conducted an in-person medical evaluation, provided all of the following conditions are met: The prescription is issued for a legitimate medical purpose by a practitioner acting in the usual course of his/her professional… [read post]